Dr. Amon Asgharpour, MD

Dr. Asgharpour practices at VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia.

Dr. Asgharpour's NPI, 1720221278, was assigned on April 14, 2009. Dr. Asgharpour holds New York license 289839.

Dr. Asgharpour's primary practice is VCU Medical Center, at 1250 East Marshall Street, Richmond, VA 23298 in Richmond City. The practice phone is (804) 828-9000.

Dr. Asgharpour's primary practice is VCU Medical Center in Richmond, Virginia, part of Commonwealth of Virginia. Dr. Asgharpour is also affiliated with The Mount Sinai Hospital. The medical group on file is MCV Physicians. Dmand AI also links Dr. Asgharpour to 2 more hospitals, 1 group practice or clinic, 1 urgent care center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Asgharpour practices, 6 sites in all. Vendor and product names are available with a free account.

Transplant hepatology is Dr. Asgharpour's primary specialty in the NPI Registry, under taxonomy code 207RT0003X. Dr. Asgharpour is licensed in New York.

CMS data shows 202 Medicare services from Dr. Asgharpour across 6 procedure codes in 2024, for 160 Medicare patients. Medicare paid $13,649 for them.

CMS counts 160 Medicare patients who saw Dr. Asgharpour in 2024. The largest group is 65 to 74, with 89 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Asgharpour's median patient age at 68, with 52% women.

In 2024, Dr. Asgharpour wrote 192 Medicare Part D claims for 40 patients. 93% of them were for generic drugs. CMS names the drug for 126 of them, across 6 drugs with 11 or more claims each, at $63,769 in total drug cost. In 2023, CMS named 129 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Asgharpour for performance year 2024, reported as part of a group. Dr. Asgharpour accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Asgharpour, more than 45% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 34 papers to Dr. Asgharpour, published from 2015 to 2025. 2024 was the busiest year, with 9. The most frequent topics are Non-alcoholic Fatty Liver Disease, Liver Cirrhosis and Fatty Liver. Dr. Asgharpour has published most often in Clin Gastroenterol Hepatol. Dr. Asgharpour's most frequent co-authors are Mohammad S. Siddiqui, MD, Douglas T. Dieterich, MD and Scott C. Matherly, MD.

Dmand AI links Dr. Asgharpour to 2 clinical trials. Conditions studied include Non-alcoholic Fatty Liver Disease and Fatty Liver. Open Payments lists research payments to Dr. Asgharpour that name 1 trial.

CMS Open Payments shows 102 general payments to Dr. Asgharpour from 17 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 42% of the total. Intercept Pharmaceuticals, Inc. paid the most, $44,136. It also lists 2 research payments totaling $223 from 2019 to 2020, naming 1 clinical trial.